LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Strona główna・Stock List・Abbott Laboratories

Abbott Laboratories

Closed

Sector Healthcare

105.07 -0.96

Buy Sell

Overview

Share price change

24h

Current

Min

104.65

Max

107.11

Key metrics
By Trading Economics
Income	-369M 1.2B
Sales	-281M 10B
P/E Sector Avg	34.87 79.786
EPS	0.98
Profit margin	12.299
Employees	114,000
EBITDA	-28M 2.4B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+19.62 upside

Dividends
By Dow Jones
Next Earnings	16 paź 2024
Next Dividend date	15 sie 2024
Next Ex Dividend date	10 paź 2024

Market Stats
By TradingEconomics
Market Cap	-555M 179B
Previous open	106.03
Previous close	105.07

News Sentiment

By Acuity

41%

59%

97 / 369 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

104.18 / 107.26 Support & Resistance

Abbott Laboratories Chart

Related News

18 lip 2024, 12:21 UTC

Earnings

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

18 lip 2024, 19:04 UTC

Market Talk

Earnings

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 lip 2024, 11:43 UTC

Earnings

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 lip 2024, 11:34 UTC

Earnings

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 lip 2024, 11:34 UTC

Earnings

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18 lip 2024, 11:31 UTC

Earnings

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Sales $10.38B >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Adj EPS $1.14 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Net $1.3B >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q EPS 74c >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Raises Full-Yr Guidance

14 lip 2024, 22:41 UTC

Earnings

Stocks Poised for Higher Open -- Barrons.com

12 lip 2024, 23:29 UTC

Acquisitions, Mergers, Takeovers

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

17 kwi 2024, 13:54 UTC

Earnings

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17 kwi 2024, 12:41 UTC

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

19.62% upside

12 Months Forecast

Average 126.75 USD 19.62%

High 143 USD

Low 107 USD

Based on 12 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Abbott Laboratories - Dist in the past 3 months.

Technical Score

By Trading Central

104.18 / 107.26Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

97 / 369 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.